Table 3.
Independent risk factor analysis for moderate-to-severe Fazekas-scored WMH across subtypes.
Variable | PWMH | DWMH | ||||
---|---|---|---|---|---|---|
β | OR(95%CI) | p | β | OR(95%CI) | p | |
Age (per year) | 0.088 | 1.09 (1.07–1.12) | <0.0001 | 0.033 | 1.034(1.013 ~ 1.056) | 0.001 |
Sex (Male) | −0.039 | 0.96 (0.55–1.67) | 0.888 | −0.615 | 0.541(0.287 ~ 0.986) | 0.050 |
Hypertension | 1.070 | 2.92 (1.93–4.43) | <0.0001 | 0.743 | 2.102(1.341 ~ 3.350) | 0.001 |
Coronary heart disease | 0.099 | 1.10 (0.65–1.89) | 0.716 | −0.064 | 0.938(0.552 ~ 1.566) | 0.809 |
Diabetes mellitus | 0.138 | 1.15 (0.76–1.74) | 0.513 | 0.440 | 1.553(1.022 ~ 2.363) | 0.039 |
Smoking history | 0.230 | 1.26 (0.68–2.33) | 0.462 | 0.685 | 1.983(1.037 ~ 3.876) | 0.041 |
Alcohol consumption | 0.352 | 1.42 (0.79–2.57) | 0.241 | 0.447 | 1.564(0.852 ~ 2.895) | 0.151 |
Creatinine abnormality | 0.732 | 2.07 (1.18–3.72) | 0.012 | 0.172 | 1.188(0.681 ~ 2.042) | 0.538 |
Uric acid abnormality | 0.341 | 1.41 (0.86–2.31) | 0.174 | 0.365 | 1.440(0.883 ~ 2.329) | 0.140 |
Cys-C abnormality | −0.657 | 0.52 (0.27–0.98) | 0.045 | −0.067 | 0.935(0.494 ~ 1.735) | 0.833 |
β2-MG abnormality | 0.088 | 1.09 (1.07–1.12) | 0.347 | 0.579 | 1.785(1.022 ~ 3.097) | 0.040 |
Hyperlipidemia | −0.039 | 0.96 (0.55–1.67) | 0.477 | −0.422 | 0.656(0.430 ~ 0.996) | 0.049 |
Bold values indicate statistically significant results (p < 0.05).